J. Cowan

P. R. Bourque1
J. Warman Chardon1
C. E. Pringle1
1P. R. Bourque
1J. Warman Chardon
1C. E. Pringle
Learn More
  • P. R. Bourque, C. E. Pringle, W. Cameron, J. Cowan, J. Warman Chardon
  • 2016
BACKGROUND Immunoglobulin therapy has become a major treatment option in several autoimmune neuromuscular disorders. For patients with Myasthenia Gravis (MG), intravenous immunoglobulin (IVIg) has been used for both crisis and chronic management. Subcutaneous Immunoglobulins (SCIg), which offer the advantage of home administration, may be a practical and(More)
  • 1